1832 related articles for article (PubMed ID: 34931602)
1. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
[TBL] [Abstract][Full Text] [Related]
2. The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton C; Hughes DA; Williamson P; Baker GA; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE;
Lancet; 2021 Apr; 397(10282):1363-1374. PubMed ID: 33838757
[TBL] [Abstract][Full Text] [Related]
3. The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton C; Hughes DA; Williamson P; Baker GA; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE;
Lancet; 2021 Apr; 397(10282):1375-1386. PubMed ID: 33838758
[TBL] [Abstract][Full Text] [Related]
4. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011412. PubMed ID: 29243813
[TBL] [Abstract][Full Text] [Related]
5. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011412. PubMed ID: 28661008
[TBL] [Abstract][Full Text] [Related]
6. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Nevitt SJ; Sudell M; Cividini S; Marson AG; Tudur Smith C
Cochrane Database Syst Rev; 2022 Apr; 4(4):CD011412. PubMed ID: 35363878
[TBL] [Abstract][Full Text] [Related]
7. Study protocol for a pragmatic randomised controlled trial comparing the effectiveness and cost-effectiveness of levetiracetam and zonisamide versus standard treatments for epilepsy: a comparison of standard and new antiepileptic drugs (SANAD-II).
Balabanova S; Taylor C; Sills G; Burnside G; Plumpton C; Smith PEM; Appleton R; Leach JP; Johnson M; Baker G; Pirmohamed M; Hughes DA; Williamson PR; Tudur-Smith C; Marson AG
BMJ Open; 2020 Aug; 10(8):e040635. PubMed ID: 32847927
[TBL] [Abstract][Full Text] [Related]
8. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Tudur Smith C; Weston J; Marson AG
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001031. PubMed ID: 29952431
[TBL] [Abstract][Full Text] [Related]
9. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.
Marson AG; Al-Kharusi AM; Alwaidh M; Appleton R; Baker GA; Chadwick DW; Cramp C; Cockerell OC; Cooper PN; Doughty J; Eaton B; Gamble C; Goulding PJ; Howell SJ; Hughes A; Jackson M; Jacoby A; Kellett M; Lawson GR; Leach JP; Nicolaides P; Roberts R; Shackley P; Shen J; Smith DF; Smith PE; Smith CT; Vanoli A; Williamson PR;
Lancet; 2007 Mar; 369(9566):1016-26. PubMed ID: 17382828
[TBL] [Abstract][Full Text] [Related]
10. Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Marson AG; Weston J; Tudur Smith C
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD001769. PubMed ID: 30091458
[TBL] [Abstract][Full Text] [Related]
11. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.
Nolan SJ; Tudur Smith C; Weston J; Marson AG
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD001031. PubMed ID: 27841445
[TBL] [Abstract][Full Text] [Related]
12. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.
Appleton RE; Rainford NE; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee E; Potter S; Tate P; Al Najjar N; Iyer A; Evans V; Lyttle MD
Health Technol Assess; 2020 Nov; 24(58):1-96. PubMed ID: 33190679
[TBL] [Abstract][Full Text] [Related]
13. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Sudell M; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012065. PubMed ID: 31233229
[TBL] [Abstract][Full Text] [Related]
14. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.
Marson AG; Appleton R; Baker GA; Chadwick DW; Doughty J; Eaton B; Gamble C; Jacoby A; Shackley P; Smith DF; Tudur-Smith C; Vanoli A; Williamson PR
Health Technol Assess; 2007 Oct; 11(37):iii-iv, ix-x, 1-134. PubMed ID: 17903391
[TBL] [Abstract][Full Text] [Related]
15. Cognitive-behavioural therapy compared with standardised medical care for adults with dissociative non-epileptic seizures: the CODES RCT.
Goldstein LH; Robinson EJ; Pilecka I; Perdue I; Mosweu I; Read J; Jordan H; Wilkinson M; Rawlings G; Feehan SJ; Callaghan H; Day E; Purnell J; Baldellou Lopez M; Brockington A; Burness C; Poole NA; Eastwood C; Moore M; Mellers JD; Stone J; Carson A; Medford N; Reuber M; McCrone P; Murray J; Richardson MP; Landau S; Chalder T
Health Technol Assess; 2021 Jun; 25(43):1-144. PubMed ID: 34196269
[TBL] [Abstract][Full Text] [Related]
16. Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD003615. PubMed ID: 30350354
[TBL] [Abstract][Full Text] [Related]
17. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Marson AG; Tudur Smith C
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001904. PubMed ID: 30353945
[TBL] [Abstract][Full Text] [Related]
18. AntiEpileptic drug Monitoring in PREgnancy (EMPiRE): a double-blind randomised trial on effectiveness and acceptability of monitoring strategies.
Thangaratinam S; Marlin N; Newton S; Weckesser A; Bagary M; Greenhill L; Rikunenko R; D'Amico M; Rogozińska E; Kelso A; Hard K; Coleman J; Moss N; Roberts T; Middleton L; Dodds J; Pullen A; Eldridge S; Pirie A; Denny E; McCorry D; Khan KS
Health Technol Assess; 2018 May; 22(23):1-152. PubMed ID: 29737274
[TBL] [Abstract][Full Text] [Related]
19. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.
Nolan SJ; Sudell M; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD012065. PubMed ID: 27922722
[TBL] [Abstract][Full Text] [Related]
20. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Marson AG; Tudur Smith C
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001911. PubMed ID: 31318037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
